Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers
- PMID: 37729043
- PMCID: PMC10545069
- DOI: 10.1097/LGT.0000000000000763
Understanding Sexual and Gender Minority Populations and Organ-Based Screening Recommendations for Human Papillomavirus-Related Cancers
Abstract
Objectives: Sexual gender minority (SGM) populations are at risk for human papillomavirus (HPV)-related cancers of the anogenital tract and oropharynx and often face barriers to health care. The goals of this document are to clarify language to provide inclusive care for SGM populations and to provide recommendations for screening and prevention of HPV-related cancers in SGM populations.
Materials and methods: An expert committee convened by the American Society for Colposcopy and Cervical Pathology performed a narrative review of the literature through February 2023. A comprehensive MEDLINE database search was performed for relevant studies. The literature review was divided into categories by organ/topic and by SGM population. Given the variability in available data for several of the categories, recommendations were made based on national guidelines where appropriate or expert opinion where there were less data to support risk-based guidelines.
Results: Definitions and terminology relevant to SGM populations are presented. The authors advocate the adoption of sexual orientation gender identity data collection and an organ-based screening approach, which is possible with knowledge of patient anatomy, sexual behaviors, and clinical history. This includes screening for cervical cancer per national recommendations, as well as screening for anal, vulvar, vaginal, penile, and oral cancers based on risk factors and shared clinical decision making. The authors recommend consideration of HPV vaccination in all SGM individuals up to age 45 years old who are at risk.
Conclusions: An organ-based screening approach is part of a global strategy to create an inclusive care environment and mitigate barriers to screening and prevention of HPV-mediated cancers in SGM populations.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCCP.
Conflict of interest statement
The authors have declared they have no conflicts of interest.
Figures
Comment in
-
Commentary on New Guidance for Human Papillomavirus-Related Cancer Screening Among Sexual and Gender Minority Populations.J Low Genit Tract Dis. 2023 Oct 1;27(4):322-323. doi: 10.1097/LGT.0000000000000764. J Low Genit Tract Dis. 2023. PMID: 37729044 No abstract available.
References
-
- Simelela PN. WHO global strategy to eliminate cervical cancer as a public health problem: an opportunity to make it a disease of the past. Int J Gynaecol Obstet 2021;152:1–3. - PubMed
-
- Institute of Medicine Committee on Lesbian, G.B, et al. The National Academies Collection: Reports funded by National Institutes of Health, in The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington (DC): National Academies Press (US), National Academy of Sciences; 2011. - PubMed
-
- Eliseo J, Pérez-Stable MD, NIMHD director statement in support of diverse and inclusive speaking panels. June 21, 2019. Available at: https://www.nimhd.nih.gov/about/directors-corner/messages/message_06-21-.... Accessed May 30, 2023.
